GAIIS 2022 witnesses LoIs worth more than Rs 9000 Cr in major Ayush categories

22 April 2022 | News

Five significant MoUs were signed in the presence of Prime Minister Narendra Modi

image credit- twitter

image credit- twitter

Creating a  history, India’s first Global Ayush Investment and Innovation Summit (GAIIS) 2022 held in Gandhinagar, Gujarat witnessed letters of intent (LoIs) worth more than Rs 9000 crore  in major categories like FMCG, Medical Value Travel (Heal in India), Pharma, Technology & Diagnostic and Farmers & Agriculture.

The assurances of investment include more than Rs. 7000 crore from FMCG, around Rs 1000 crore from Medical Value Travel (MVT), around Rs 345 Crores from Pharma sector, Rs 300 crore for Farmers & Agri category and around Rs 60 crore  in the Technology & Diagnostic category.

A total of 12 MoUs were signed between the Central Council for Research in Ayurveda Sciences (CCRAS), Ministry of Ayush and various prestigious research institutes in the country. The institutes include IIT Delhi, IIT Guwahati, ICMR NITM, AIIMS, CSIR, NIPER, NIMHANS, JNU, ICGB, AVP, TDU.

One among international MoUs signed was between the Rashtriya Ayurveda Vidyapeeth (RAV), Ministry of Ayush and Fundacion de Salud Ayurveda prema (Ayurveda Prema Health Foundation), Argentina in the field of “the establishment of an academia collaboration in Ayurveda”. 

Anothertripartite MoU was signed between All India Institute of Ayurveda (AIIA), Federal University of Rio de Janeiro (UFRJ), Brazil & Brazilian Academic Consortium for Integrative Health (CABSIN), Brazil on the establishment of academic collaboration in Ayurveda. This will promote collaborations on research, advocating safety in the use of Ayurveda in Brazil.

An MoU was also signed between All Indian Institute of Ayurveda, Ministry of Ayush and University Health Network, Toronto (UHN), Canada to explore fellowship and graduate student training and mutual collaborations for training of medical doctors and allied health professionals etc.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account